≡ Risteys
R8

Documentation Changelog GitHub Contact & Feedback

Use of amantadine

PheWeb

PDMED_AMANTADINE

No definition available.

Endpoint definition

↥
FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC N04BB01

1860

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

366

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

366

diagram downward connector

Include endpoints None

366

diagram downward connector
PDMED_AMANTADINE

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 366 245 121
Unadjusted prevalence (%) 0.10 0.12 0.08
Mean age at first event (years) 52.51 49.48 58.65

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: PDMED_AMANTADINE – Use of amantadine
GWS hits:

Survival analyses between endpoints

↥

Plot

before Use of amantadine
after Use of amantadine

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Use of amantadine

↥